Financhill
Back

Editas Medicine Vs. Regeneron Pharmaceuticals Industry Stock Comparison

Sell
49

EDIT
Editas Medicine

Last Price:
3.28
Seasonality Move:
21.39%
Sell
37

REGN
Regeneron Pharmaceuticals

Last Price:
816.56
Seasonality Move:
11.8%
Sell
49
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $3.12. The Score for EDIT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Regeneron Pharmaceuticals (REGN) is a Sell

Is Regeneron Pharmaceuticals a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals [REGN] share price is $829.43. The Score for REGN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $3.12
    The current trend is relatively stagnant and EDIT is experiencing buying pressure, which is a positive indicator for future bullish movement.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals's stock price today?

  • The Regeneron Pharmaceuticals share price today is $829.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 45.93 Sell
Chaikin Money Flow: 1568900 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.01 - 3.39) Sell
Bollinger Bands (100): (3.3 - 4.98) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -57.31 Sell
Relative Strength Index (14 RSI): 13.94 Sell
Chaikin Money Flow: 109670 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (895.28 - 1026.78) Sell
Bollinger Bands (100): (983.53 - 1152.51) Sell

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.05 Buy
20-day SMA: 3.18 Sell
50-day SMA: 3.44 Sell
200-day SMA: 5.51 Sell
8-day EMA: 3.05 Buy
20-day EMA: 3.18 Sell
50-day EMA: 3.51 Sell
200-day EMA: 5.28 Sell

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 881.48 Sell
20-day SMA: 945.74 Sell
50-day SMA: 1047.97 Sell
200-day SMA: 1011.95 Sell
8-day EMA: 873.49 Sell
20-day EMA: 932.64 Sell
50-day EMA: 1004.92 Sell
200-day EMA: 999.95 Sell

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.37 per share, and an increase next year of $0.05 per share.

Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.30 per share, and an increase next year of $0.75 per share.

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):